Du, Fen
Wumener, Xieraili
Zhang, Yarong
Zhang, Maoqun
Zhao, Jiuhui
Zhou, Jinpeng
Li, Yiluo
Huang, Bin
Wu, Rongliang
Xia, Zeheng
Yao, Zhiheng
Sun, Tao
Liang, Ying
Funding for this research was provided by:
Key Laboratory for Magnetic Resonance and Multimodality Imaging of Guangdong Province (2023B1212060052)
Shenzhen Science and Technology Innovation Committee (20220531100209020)
Department of Science and Technology of Guangdong Province (2022A1515110716)
the Shenzhen Science and Technology Program of China (JCYJ20220818101804009)
Shenzhen High-level Hospital Construction Fund (Shenzhen High-level Hospital Construction Fund)
National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen (E010322003, SZ2020MS008)
Article History
Received: 20 November 2023
Accepted: 27 February 2024
First Online: 5 March 2024
Declarations
:
: This prospective study was approved by the ethics committee of Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences (Clinical Trial Number: KYLH2022-1), which followed the 1964 Helsinki Declaration ethical standards and its subsequent amendments. All patients were provided written informed consent.
: Not applicable.
: The authors declare that they have no competing interests.